Ovizio - About the company
Ovizio is a series A company based in Brussels (Belgium), founded in 2009 by . It operates as a Developer of an imaging system for microscopes. Ovizio has raised $9.34M in funding. The company has 245 active competitors, including 56 funded and 16 that have exited. Its top competitors include companies like PathAI, Aignostics and Pictor Labs.
Company Details
Developer of an imaging system for microscopes. The company has developed machine-learning software and microscopes. It has developed an AI-based software called OsOne which can provide the 3D analysis of images and continuous data recording among others. Its microscopic products are iLine F, QMode, I Line engineering platform among others.
- Website
- Social
Legal entities associated with Ovizio
Ovizio is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
---|---|---|---|---|
CIN: 0821.638.597 Belgium, Active | Dec 16, 2009 | - | 16 (as on Dec 31, 2022) | - |
Get your free copy of Ovizio's company profile
Ovizio's funding and investors
Ovizio has raised a total funding of $9.34M over 5 rounds. Its first funding round was on 2009. Its latest funding round was a Grant (prize money) round on Jun 30, 2017 for $57K. 1 investor participated in its latest round, which include , EIC Fund, New Science Ventures and Theodorus.
Ovizio has 8 institutional investors including , EIC Fund and New Science Ventures.
Here is the list of recent funding rounds of Ovizio:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
---|---|---|---|---|---|
Jun 30, 2017 | $57K | Grant (prize money) | 8364177 | 6016060 | |
Jan 01, 2017 | $57.1K | Grant (prize money) | 1078765 | 3053327 | |
Jan 01, 2016 | $729K | Grant (prize money) | 4568522 | 8563891 |
View details of Ovizio's funding rounds and investors
Ovizio's founders and board of directors
The founders of Ovizio is .
Here are the details of Ovizio's key team members:
- : Former Founder & CEO of Ovizio.
View details of
Ovizio's employee count trend
Ovizio has 16 employees as of Dec 22. The total employee count is 7.0% more than what it was in Dec 21. Here is Ovizio's employee count trend over the years:Access ÃØÃÜÑо¿Ëù on any website
Our Google Chrome extension lets you view company details while browsing their websites
Ovizio's Competitors and alternates
Top competitors of Ovizio include PathAI, Aignostics and Pictor Labs. Here is the list of Top 10 competitors of Ovizio, ranked by ÃØÃÜÑо¿Ëù score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
---|---|---|---|---|---|
1st | ![]() PathAI 2016, Boston (United States), Series C | Provider of AI-based solutions for clinical diagnosis of cancer and other diseases | $255M | Adage Capital Management, General AtlanticÌý&²¹³¾±è;Ìý | 63/100 |
2nd | Aignostics 2018, Berlin (Germany), Series B | Provider of AI based pathology diagnostic software | $53.9M | Wellington Partners Venture Capital, AscenionÌý&²¹³¾±è;Ìý | 60/100 |
3rd | ![]() Pictor Labs 2019, Los Angeles (United States), Series B | AI-based solutions for pathological image analysis | $48.8M | Insight Partners, M VenturesÌý&²¹³¾±è;Ìý | 59/100 |
4th | Visiopharm 2001, Horsholm (Denmark), Series B | Developer of a SaaS and AI-based digital pathology solutions for image analysis and workflow standardization | $26.3M | ATP, BankInvestÌý&²¹³¾±è;Ìý | 57/100 |
5th | Provider of medical imaging software and services for clinical trials usage | $5.28M | Abingworth, Omega FundsÌý&²¹³¾±è;Ìý | 56/100 | |
6th | Developer of AI-based imaging biomarkers for clinical care, research, and drug development | $60M | , Amadeus CapitalÌý&²¹³¾±è;Ìý | 54/100 | |
7th | Developer of wall-less plates and washers for automated cell-based assays | $30M | IMM Investment, SV INVESTMENTÌý&²¹³¾±è;Ìý | 54/100 | |
8th | 2009, Brussels (Belgium), Series A | Developer of an imaging system for microscopes | $9.34M | , EIC FundÌý&²¹³¾±è;Ìý | 54/100 |
9th | Developer of solutions for clinical proteomics | $48.8M | Novo Holdings, VaekstfondenÌý&²¹³¾±è;Ìý | 54/100 | |
10th | ![]() Nucleai 2017, Chicago (United States), Series B | AI-assisted platform for image analysis | $60M | Sanofi Ventures, Vertex Ventures IsraelÌý&²¹³¾±è;Ìý | 53/100 |
Looking for more details on Ovizio's competitors? Click to see the top ones
Ovizio's Investments and acquisitions
Ovizio has made no investments or acquisitions yet.
Reports related to Ovizio
Here is the latest report on Ovizio's sector:
View
News related to Ovizio
Media has covered Ovizio for a total of 3 events in the last 1 year.
•
•
•
•
•
•
•
Life-Sciences-Germany•Jul 05, 2018•Ovizio
•
Are you a Founder ?
FAQ's about Ovizio
Explore our recently published companies
- Catxp - United Kingdom based, 2010 founded, Unfunded company
- Dual Therapeutics - Unfunded company
- BioBus - United States based, 2008 founded, Unfunded company
- HOWARD BAER, INC. - United States based, Deadpooled company
- NeoCrop - Valdivia based, 2021 founded, Seed company
- PortmanDentex - Cheltenham based, 2008 founded, Unfunded company